• News
  • SAN DIEGO
  • BioTech

Orexigen appoints Endicott to board

Orexigen Therapeutics Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, Friday announced the appointment of David Endicott to its board of directors.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Orexigen Therapeutics Inc.

Company Website

3344 North Torrey Pines Ct. Ste., 200
La Jolla, CA 92037

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
OREX
5.89
  0.23  
+ 4.06%
5,437,840,000
7.82
4.59

Orexigen Therapeutics Inc. Executive(s):

Michael Narachi

  • Chief Executive Officer, President

Similar Companies

NAICS - 325412 - Pharmaceutical Preparation Manufacturing
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
SIC - 2834 - PHARMACEUTICAL PREPARATIONS
Subscribe Today!